
Successful Use of Two Thrombolytic Drugs in Prosthetic Mitral and Aortic Valve Thrombosis
Author(s) -
Shayesteh Gheibi,
Aliasghar Farsavian,
Maryam Nabati,
Gohar Eslami
Publication year - 2020
Publication title -
pharmaceutical and biomedical research
Language(s) - English
Resource type - Journals
eISSN - 2423-4494
pISSN - 2423-4486
DOI - 10.18502/pbr.v5i4.2399
Subject(s) - medicine , streptokinase , thrombosis , prosthesis , surgery , mitral valve replacement , cardiology , complication , mitral valve , mechanical valve , adverse effect , myocardial infarction
Prosthetic valve thrombosis is a rare and severe complication of valve
replacement, most often encountered with a mechanical prosthesis. The significant morbidity
and mortality associated with this condition warrant rapid diagnostic evaluation. Although
surgery is the first-line therapy in symptomatic obstructive mechanical valve thrombosis,
thrombolytic therapy has been used as an alternative.
Case Description: In this case report, we describe a 46-year-old man with a history of the
mitral valve and aortic valve replacement 2 years ago. In echocardiography, we detected a
mobile mass on the atrial side of the mitral valve prosthesis and a fixed one on the leaflet of
the mechanical aortic valve with a high gradient. To save his life, we used double thrombolytic
therapy considering the patient’s hemodynamic situation and the risk of bleeding. Although
a routine dose of reteplase and streptokinase was considered, we administered these two
thrombolytic drugs together within 72 hours.
Conclucsion: Ultimately we succeeded with this method without any significant or life-threatening
adverse effects, and the patient was discharged after an optimal anticoagulation therapy.